Immunotherapy wipes out some colorectal tumors without surgery, signaling a major shift toward less invasive treatment.

A short course of immunotherapy given before surgery eliminated detectable colon cancer in a majority of patients whose ...

Time for a gut check. Cases of colorectal cancer are on the rise, surpassing breast and brain cancer as the leading cause of ...

At MSK, close to half of the surgeries just for colorectal cancer are done robotically, Dr. Garcia-Aguilar says. A leader in ...

A team led by researchers from the German Cancer Research Center (DKFZ) and the HI-STEM Stem Cell Institute has discovered a promising new approach to treating advanced colorectal cancer. The study, ...

Tumor deposits are a significant prognostic factor in colorectal cancer, yet underutilized in N-staging. Ten novel models incorporating tumor deposits showed improved prognostic performance over the ...

Determining the presence of a protein in non-tumor cells within the cancer microenvironment could be one of the keys to establishing prognosis in patients with colon and rectal cancer. It may also ...

An experimental cancer vaccine has shown promise in keeping certain cancers from coming back. In a phase 1 clinical trial led in part by the UCLA Health Jonsson Comprehensive Cancer Center, ...

Colorectal cancer is one of the leading causes of cancer death worldwide. In recent years, immunotherapies-treatments that reactivate the immune system to attack tumor cells-have transformed the ...

An experimental cancer vaccine has shown promise in keeping certain cancers from coming back. In a phase 1 clinical trial led in part by the UCLA Health Jonsson Comprehensive Cancer Center, ...

It's stage III and contained.

ESMO GI poster highlights increased intratumoral CD8+ T-cell infiltration, PD-L1 expression, expansion of tumor-reactive TCR clonotypes and association with clinical outcome ...